FDA calendar · June 2020 · built from SEC filings

PDUFA dates June 2020: FDA calendar and catalysts.

Updated Snapshot 20261116T222116ZBuilt

0 PDUFA dates fell in June 2020. The FDA calendar also recorded 24 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in June 2020

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

June 2020: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
June 4, 2020Recarbrio (cilastatin sodium; imipenem; relebactam)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
June 4, 2020Inlyta (axitinib)PFELabel expansion—ApprovedopenFDA Drugs@FDA
June 9, 2020Prolia® (denosumab)AMGNLabel expansion—ApprovedopenFDA Drugs@FDA
June 9, 2020Bridion (sugammadex sodium)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
June 10, 2020Opdivo® (nivolumab)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
June 10, 2020Nyvepria (pegfilgrastim-apgf)PFEFDA approval—ApprovedopenFDA Drugs@FDA
June 11, 2020Semglee (insulin glargine)VTRSFDA approval—ApprovedopenFDA Drugs@FDA
June 12, 2020Strensiq (asfotase alfa)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
June 12, 2020Tivicay (dolutegravir sodium)GSKFDA approval—ApprovedopenFDA Drugs@FDA
June 12, 2020Tivicay (dolutegravir sodium)GSKLabel expansion—ApprovedopenFDA Drugs@FDA
June 15, 2020Zepzelca (lurbinectedin)JAZZFDA approval—ApprovedopenFDA Drugs@FDA
June 15, 2020Lyumjev (insulin lispro-aabc)LLYFDA approval—ApprovedopenFDA Drugs@FDA
June 16, 2020SPINRAZA (nusinersen)BIIBLabel expansion—ApprovedopenFDA Drugs@FDA
June 16, 2020KEYTRUDA® (pembrolizumab)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
June 16, 2020Ilaris (canakinumab)NVSLabel expansion—ApprovedopenFDA Drugs@FDA
June 16, 2020Cosentyx (secukinumab)NVSLabel expansion—ApprovedopenFDA Drugs@FDA
June 16, 2020Mylotarg (gemtuzumab ozogamicin)PFELabel expansion—ApprovedopenFDA Drugs@FDA
June 18, 2020Dupixent (dupilumab)REGNLabel expansion—ApprovedopenFDA Drugs@FDA
June 25, 2020Libtayo (cemiplimab-rwlc)REGNLabel expansion—ApprovedopenFDA Drugs@FDA
June 26, 2020ZYNRELEF® (bupivacaine-meloxicam)HRTXComplete Response Letter—CRL issuedFDA Complete Response Letters
June 26, 2020Lialda (mesalamine)TAKLabel expansion—ApprovedopenFDA Drugs@FDA
June 29, 2020DARZALEX (daratumumab)JNJLabel expansion—ApprovedopenFDA Drugs@FDA
June 29, 2020KEYTRUDA® (pembrolizumab)MRKLabel expansion—ApprovedopenFDA Drugs@FDA
June 30, 2020Retacrit (epoetin alfa-epbx)PFELabel expansion—ApprovedopenFDA Drugs@FDA

June 2020: dated readouts

No events in this view.

Questions

What PDUFA dates are in June 2020?

0 PDUFA dates fell in June 2020. The FDA calendar also recorded 24 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.